Amgen Inc. is buying a $66 million stake in Oxford Nanopore Technologies Ltd., whose small, portable DNA sequencer has made it a darling of U.K. genetics work.
Oxford Nanopore makes a range of genetic-sequencing technologies but it’s best known for the MinION, a pocket-sized sequencer that for $1,000 gives scientists the ability to study life essentially in real time -- and has sequenced genes in destinations as far-flung as space. Earlier this month, the company released the MinIT, a tiny data-analysis tool that makes the MinION more portable and powerful.
DNA sequencing and the huge amounts of data ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.